Geron Corp
GERNNasdaqCIK 886744HealthcareFiscal year ends Dec 31
Reports and events: 338 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0610:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336508 |
| 2026-08-0520:41 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000886744-26-000037 |
| 2026-05-2720:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-241842 |
| 2026-05-0620:49 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000886744-26-000032 |
| 2026-04-0720:30 ET | DEF 14A | Proxy statementPeriod 2026-05-20 | 0000886744-26-000024 |
| 2026-03-2612:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-125151 |
| 2026-03-0212:11 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000886744-26-000008 |
| 2026-02-2512:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-068523 |
| 2026-01-1213:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000886744-26-000003 |
| 2026-01-0611:01 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-26-003388 |
| 2025-12-1621:01 ET | 8-K | 2.05 Exit or disposal costs | 0000886744-25-000074 |
| 2025-11-0721:11 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000886744-25-000071 |
| 2025-11-0512:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886744-25-000068 |
| 2025-10-1412:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-044862 |
| 2025-08-0620:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000886744-25-000054 |
| 2025-08-0620:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000886744-25-000052 |
| 2025-08-0611:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886744-25-000048 |
| 2025-05-2720:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000886744-25-000032 |
| 2025-05-0720:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000886744-25-000010 |
| 2025-05-0711:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000886744-25-000007 |
| 2025-04-0820:06 ET | DEF 14A | Proxy statementPeriod 2025-05-21 | 0001140361-25-012825 |
| 2025-03-1720:10 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0000950170-25-040247 |
| 2025-03-1120:54 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-037260 |
| 2025-02-2722:33 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-027982 |
| 2025-02-2612:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027331 |
| 2025-01-1313:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004579 |
| 2024-11-0721:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123282 |
| 2024-11-0712:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122771 |
| 2024-08-0820:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093950 |
| 2024-08-0811:10 ET | 8-K | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093307 |
| 2024-06-0720:03 ET | 8-K | 8.01 Other events | 0000950170-24-070574 |
| 2024-05-1320:05 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-058622 |
| 2024-05-0220:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-052074 |
| 2024-05-0211:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051565 |
| 2024-03-2720:51 ET | DEF 14A | Proxy statementPeriod 2024-05-09 | 0001140361-24-015662 |
| 2024-03-2001:32 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-24-033921 |
| 2024-03-1910:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-033142 |
| 2024-03-1420:08 ET | 8-K | 8.01 Other events | 0000950170-24-031475 |
| 2024-02-2821:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-022056 |
| 2024-02-2812:20 ET | 8-K | 2.02 Results of operations | 0000950170-24-021658 |
| 2024-01-3013:00 ET | 8-K | 8.01 Other events | 0000950170-24-008536 |
| 2024-01-0813:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002722 |
| 2023-12-1521:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws | 0000950170-23-070765 |
| 2023-11-2821:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-066396 |
| 2023-11-0212:50 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-057772 |
| 2023-11-0212:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-057760 |
| 2023-09-2913:02 ET | 8-K | 8.01 Other events | 0000950170-23-050580 |
| 2023-09-1201:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-047555 |
| 2023-08-2220:59 ET | 8-K | 8.01 Other events | 0000950170-23-043949 |
| 2023-08-0320:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-038061 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.